ANRO
ANRO
US02157Q1094
Alto Neuroscience, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
956.33M EUR
926.13M EUR
787.99M EUR
568.24M EUR
Enterprise Value
722.55M EUR
705.69M EUR
547.44M EUR
415.71M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.42x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.9x
4.22x
3.24x
3.76x
EV/Revenue
--
--
--
--
EV/EBITDA
-8.25x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.49%
-7.43%
-7.98%
-6.2%
ende